UCE6是一种来自放线菌的新型抗肿瘤抗生素，具有拓扑异构酶I介导的DNA切割活性。 - Suppr | 超能文献

UCE6, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes.

作者信息

Fujii N, Yamashita Y, Chiba S, Uosaki Y, Saitoh Y, Tuji Y, Nakano H

出版信息

J Antibiot (Tokyo). 1993 Jul;46(7):1173-4. doi: 10.7164/antibiotics.46.1173.

DOI:10.7164/antibiotics.46.1173

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

UCE6, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes.UCE6是一种来自放线菌的新型抗肿瘤抗生素，具有拓扑异构酶I介导的DNA切割活性。

J Antibiot (Tokyo). 1993 Jul;46(7):1173-4. doi: 10.7164/antibiotics.46.1173.

2

UCE6, a new antitumor antibiotic with topoisomerase I-mediated DNA cleavage activity produced by actinomycetes: producing organism, fermentation, isolation and biological activity.UCE6，一种由放线菌产生的具有拓扑异构酶I介导的DNA切割活性的新型抗肿瘤抗生素：产生菌、发酵、分离及生物活性

J Antibiot (Tokyo). 1997 Jun;50(6):490-5. doi: 10.7164/antibiotics.50.490.

3

Correlation between the formation of cleavable complex with topoisomerase I and growth-inhibitory activity for saintopin-type antibiotics.喜树碱类抗生素与拓扑异构酶I形成可裂解复合物的能力与其生长抑制活性之间的相关性。

Mol Pharmacol. 1997 Feb;51(2):269-76. doi: 10.1124/mol.51.2.269.

4

UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces.UCE1022，一种来自拟青霉的具有拓扑异构酶I介导的DNA切割活性的新型抗肿瘤抗生素。

J Antibiot (Tokyo). 1994 Aug;47(8):949-51. doi: 10.7164/antibiotics.47.949.

5

Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.新型真菌抗肿瘤剂圣托品诱导哺乳动物DNA拓扑异构酶I和II介导的DNA裂解

Biochemistry. 1991 Jun 18;30(24):5838-45. doi: 10.1021/bi00238a005.

6

Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110.新型吲哚咔唑ED-110诱导拓扑异构酶I介导的DNA切割

Cancer Res. 1993 Feb 1;53(3):490-4.

7

Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.吗啉基阿霉素、阿霉素和放线菌素D对哺乳动物DNA拓扑异构酶I和II的影响。

Mol Pharmacol. 1990 Jul;38(1):38-45.

8

BMS-181184, a new pradimicin derivative. Screening, taxonomy, directed biosynthesis, isolation and characterization.

J Antibiot (Tokyo). 1993 Feb;46(2):265-74. doi: 10.7164/antibiotics.46.265.

9

Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts.抗肿瘤药物VM 26、福司曲星和喜树碱导致的拓扑异构酶中毒对哺乳动物细胞提取物DNA修复复制的影响。

Carcinogenesis. 1992 Aug;13(8):1371-7. doi: 10.1093/carcin/13.8.1371.

10

Novel antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity.新型抗肿瘤抗生素CI-940（PD 114,720）和PD 114,721。分类学、发酵及生物活性。

J Antibiot (Tokyo). 1985 Apr;38(4):460-5. doi: 10.7164/antibiotics.38.460.

引用本文的文献

1

Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.动力学分析揭示DNA拓扑异构酶I和II抑制剂之间不同的细胞杀伤作用模式。

Jpn J Cancer Res. 1994 Feb;85(2):187-93. doi: 10.1111/j.1349-7006.1994.tb02081.x.